Rapamycin and hydronephrosis 
Rapamycin and hydronephrosis Patient Reports February 12, 2012
Rapamycin Side Effects Report #5020530-1
Rapamycin side effect was reported by a Health Professional from UNITED STATES on June 07, 2006. Female patient, weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and was treated with Rapamycin. After drug was administered, patient experienced the following side effects: dehydration, disease progression, hydronephrosis, nausea
, renal failure acute. Rapamycin dosage: 5 MG WEEKLY PO. During the same period patient was treated with KETOCONAZOLE. Patient was hospitalized. Patient recovered.Rapamycin Side Effects Report #5020540-4
Rapamycin side effect was reported by a Health Professional from UNITED STATES on June 07, 2006. Female patient, weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and was treated with Rapamycin. After drug was administered, patient experienced the following side effects: dehydration, disease progression, hydronephrosis, renal failure acute. Rapamycin dosage: 5 MG WEEKLY PO. During the same period patient was treated with KETOCONAZOLE. Patient was hospitalized. Patient recovered.
Rapamycin Side Effects Report #5020946-3
Rapamycin side effect was reported by a Health Professional from UNITED STATES on June 07, 2006. Female patient, weighting 119.0 lb, was diagnosed with ovarian cancer metastatic and was treated with Rapamycin. After drug was administered, patient experienced the following side effects: dehydration, disease progression, hydronephrosis, nausea
, renal failure acute. Rapamycin dosage: 5 MG WEEKLY PO. During the same period patient was treated with KETOCONAZOLE. Patient was hospitalized. Patient recovered.Rapamycin Side Effects Report #5958147-4
Rapamycin side effect was reported by a Health Professional from UNITED STATES on Nov 17, 2008. Male patient, weighting 191.8 lb, was diagnosed with colorectal cancer metastatic and was treated with Rapamycin. After drug was administered, patient experienced the following side effects: ascites, bradycardia, dehydration, hydronephrosis, pleural effusion, small intestinal obstruction. Rapamycin dosage: 16MG Q WEEK PO. During the same period patient was treated with KETOCONAZOLE. Patient recovered.